Skip to contentI
InspireMD, Inc.
I
NSPRInspireMD, Inc. Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$3.15M$3.15Mderived+61.6% vs Q4 2024 Net Income-$11.76M-$11.76MderivedN/M vs Q4 2024 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
InspireMD, Inc. · CIK 1433607 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$1,180,000+151.6% Operating Incomederived-$12,084,000N/M Operating Cash Flowderived-$9,345,000N/M Free Cash Flowderived-$9,743,000N/M Margins · derivedGross margin37.5%+13.4 pt vs Q4 2024
Operating margin-383.7%+96.9 pt vs Q4 2024
Net margin-373.5%+97.2 pt vs Q4 2024
ended Dec 31, 2025 · filed Mar 18, 2026 · 77 d after period end